| Product Code: ETC13165010 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Oncology Molecular Diagnostic Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Oncology Molecular Diagnostic Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 Africa Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.9 Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Africa Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Oncology Molecular Diagnostic Market Trends |
6 Africa Oncology Molecular Diagnostic Market, 2021 - 2031 |
6.1 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.1.3 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.1.4 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Colorectal Cancer, 2021 - 2031 |
6.1.5 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Cervical Cancer, 2021 - 2031 |
6.1.6 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Liver Cancer, 2021 - 2031 |
6.1.7 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.1.8 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Blood Cancer, 2021 - 2031 |
6.1.9 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.2.3 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Reagents, 2021 - 2031 |
6.2.4 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.3 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Other Establishments, 2021 - 2031 |
6.3.4 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Point of Care, 2021 - 2031 |
6.4 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By PCR, 2021 - 2031 |
6.4.3 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Multiplex, 2021 - 2031 |
6.4.4 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4.5 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By In Situ Hybridization, 2021 - 2031 |
6.4.6 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021 - 2031 |
6.4.7 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Chips and Microarrays, 2021 - 2031 |
6.4.8 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Mass Spectrometry, 2021 - 2031 |
6.4.9 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
7 Africa Oncology Molecular Diagnostic Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 South Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Egypt Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Nigeria Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Rest of Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
7.3.1 South Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.2 Egypt Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.3 Nigeria Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.4 Rest of Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.4.1 South Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.4.2 Egypt Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.4.3 Nigeria Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.4.4 Rest of Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Test Location, 2021 - 2031 |
7.5 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 South Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Egypt Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Nigeria Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.4 Rest of Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6 Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 South Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Egypt Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Nigeria Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.4 Rest of Africa Oncology Molecular Diagnostic Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Africa Oncology Molecular Diagnostic Market Key Performance Indicators |
9 Africa Oncology Molecular Diagnostic Market - Export/Import By Countries Assessment |
10 Africa Oncology Molecular Diagnostic Market - Opportunity Assessment |
10.1 Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
10.4 Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
10.5 Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.6 Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Africa Oncology Molecular Diagnostic Market - Competitive Landscape |
11.1 Africa Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2022 |
11.2 Africa Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here